all report title image

VITREOUS TAMPONADES MARKET ANALYSIS

Vitreous Tamponades Market, By Product Type (Gaseous Tamponades Liquid Tamponades, Silicone Oil, Perfluoroethane, Others), By Application (Retinal detachment, Macular hole, Endophthalmitis, Intraocular tumors, Vitreous hemorrhage, Others) , By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Jul 2024
  • Code : CMI1193
  • Pages :145
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Concentration and Competitive Landscape

Vitreous Tamponades Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Growing awareness regarding vitreoretinal disorders

Growing awareness about vitreoretinal disorders and their treatment options can drive the global vitreous tamponades market growth. Various vision impairment organizations and nonprofit eye care providers across the world have intensified their efforts to educate people about various retina-related conditions like retinal detachment, macular pucker/hole, and proliferative vitreoretinopathy. This has translated to more patients seeking medical attention at early stages. Furthermore, advancements in ophthalmic surgery techniques with the aid of improved tamponade agents have boosted the clinical outcomes for vitreoretinal procedures. Temporary tamponades like silicone oils and long-acting gas bubbles help surgeons achieve longer lasting retinal reattachment during complex retinal detachment repair. In 2021, according to the report published by the International Agency for the Prevention of Blindness, over 1.1 million vitrectomy surgeries were performed worldwide for various vitreoretinal disorders. A major portion of these procedures utilized some form of internal tamponade to seal retinal breaks. There will be huge demand for safer and more durable tamponades as more premium IOLs and pharmacologic vitreolysis agents become available. Surgeons would prefer agents that minimize recurrent retinal detachment risk as well as complications like elevated intraocular pressure and cataract formation.

Key Players Insights
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Novartis AG
  • Dutch Ophthalmic Research Center
  • Carl Zeiss Meditec AG
  • FCI Ophthalmics
  • Rayner Intraocular Lenses Limited
  • Arcadophtha
  • AL.CHI.MI. A Srl
  • MedOne Surgical, Inc.
  • Tamponades Retinal (TRB) Chemedica AG
  • Endo Optiks, Inc.
  • Fluoron GmbH
  • Refined Chemicals Pharmaceutical Company (RCP)
  • Guangzhou Vesber Biotechnology Co., Ltd.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.